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Background: Owing to the aging population, the number of elderly patients with critical limb 
ischemia (CLI) has increased. The consequence of amputation is immense. However, at the 
moment, information about the mortality after amputation in the elderly vascular patients 
is unknown. For this reason, this study evaluated mortality rates and patient-related factors 
associated with mortality after a major amputation in elderly patients with CLI.
Methods: From 2006 to 2013, we included patients aged .70 years who were treated for 
chronic CLI by primary or secondary major amputation within or after 3 months of initial 
therapy (revascularization or conservative management). Outcome measurements were mortality 
after major amputation and factors associated with mortality (age, comorbidity and timing of 
amputation).
Results: In total, 168/651 patients (178 legs; 26%) underwent a major amputation. Patients 
were stratified by age: 70–80 years (n=86) and .80 years (n=82). Overall mortality after major 
amputation was 44%, 66% and 85% after 1, 3 and 5 years, respectively. The 6-month and 1-year 
mortality in patients aged 80 years or older was, respectively, 59% or 63% after a secondary ampu-
tation ,3 months versus 34% and 44% after a secondary amputation .3 months. Per year of age, 
the mortality rate increased by 4% (P=0.005). No significant difference in mortality after major 
amputation was found in the presence of comorbidity or according to Rutherford classification.
Conclusion: Despite developments in the treatment of CLI by revascularization, amputation 
rates remain high and are associated with tremendous mortality rates. Secondary amputation 
after a failed attempt of revascularization causes a higher mortality. Further research concerning 
timing of amputation and patient-related outcome is needed to evaluate if selected patients might 
benefit from primary amputation.
Keywords: peripheral arterial disease, aged, limb ischemia, primary amputation, octogenarians, 
patient selection 
Introduction
In spite of ongoing improvements in the management of critical limb ischemia (CLI) 
by (endovascular) revascularization techniques, major amputations continue to be 
performed. CLI is the most advanced manifestation of peripheral arterial disease 
(PAD) as it is a chronic, arterial occlusive disease.1 The incidence of CLI is estimated 
to be 500–1,000/1 million every year, which accounts for ~1% of the total number of 
patients with PAD.2 Within a year after the onset of CLI, ~25% of the patients require 
an amputation.1 Amputations rates increase with higher Rutherford classification. 
In patients with Rutherford 6, the amputation risk is almost 60% within 1 year.3 
Patients with diabetes have an even higher need for a major amputation, up to five 
to ten times, compared to nondiabetic patients with PAD.4,5 In general, amputation 
for CLI will be performed if other therapeutic options are unavailable or have failed. 
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The implicit goal of amputation is to relieve pain, to stop 
ongoing gangrene and/or infection and to create an environ-
ment in which a wound can heal.
Besides severe morbidity, CLI is also associated with high 
mortality rates of up to 25% after 1 year and up to 64% after 
4 years of onset.1,3 Patients with CLI are often elderly patients 
with significant comorbidities and are prone to complications 
such as myocardial infarction and stroke.6 Survival rates after 
major amputation in these patients are low, with mortality 
rates up to 37% during 1 year and 49% after 2 years.7–9
The aim of this study was to evaluate mortality rates after 
major amputation in elderly patients with CLI. As major ampu-
tation is sometimes unavoidable in the treatment of CLI, we also 
attempted to gain a better understanding of the effect of timing 
of major amputation on mortality. Furthermore, we aimed to 
assess patient-related factors associated with mortality, such as 
age, gender, Rutherford classification and comorbidity.
Methods
Patients
From January 2006 to December 2013, consecutive patients 
aged 70 years or older, treated for CLI by major amputation 
in a single large teaching hospital in the Netherlands, were 
retrospectively analyzed. Data were retrieved from electronic 
patient’s records, obtained by using the Dutch diagnosis code 
for Rutherford classification stages 4–6. To compare baseline 
data and mortality rates, patients treated by conservative 
management, endovascular revascularization or surgical 
revascularization were also included. Patient characteristics, 
including age, gender, history of vascular disease (PAD, 
cardiovascular disease, cerebrovascular disease), comorbidity 
and risk factors, were registered. Smoking was recorded 
in case of current smoking. Hypertension was defined as 
use of antihypertensive medication. Diabetes mellitus was 
defined as use of antidiabetic medication. Chronic kidney 
disease was defined as an estimated glomerular filtration 
rate (eGFR) ,60 mL/min as calculated from serum creati-
nine levels using the Modification of Diet in Renal Disease 
(MRD) formula. Other comorbidities included were past or 
current cerebrovascular disease (transient ischemic attack or 
ischemic stroke), ischemic heart disease (cardiac ischemic 
event, angina or prior coronary intervention), heart failure and 
pulmonary disease (chronic obstructive pulmonary disease 
[COPD] or others). Rutherford classification was dichoto-
mized as scores 5 and 6 (ulcers and gangrene) versus score 4 
(ischemic rest pain). The Trans-Atlantic Inter-Society Con-
sensus (TASC) classification was based on duplex ultrasound, 
angiography or magnetic resonance angiography (MRA).1
Patients presenting with acute symptoms were excluded. 
In case both legs were affected during the study period, we 
included them as separate records linked to the patient.
According to the local board of the Amphia Hospital, no 
approval of an ethics committee and no informed consent 
were required. The study complies with the Declaration 
of Helsinki on research ethics, and patient data were han-
dled confidentially.
Diagnosis and treatment
Standard workup for all patients suspected of having PAD 
included ankle–brachial index (ABI) measurement. Duplex 
ultrasound or MRA was performed in selected patients to 
evaluate treatment options. All patients received statins 
and antiplatelet medication, unless an indication for anti-
coagulation was present. A dedicated multidisciplinary 
vascular team regularly reviewed the patients. The choice 
of therapeutic management was made in consensus based 
on technical possibilities and general health in individual 
patients. For the management of CLI patients, in general, 
an “endovascular first” strategy was followed. Stent was 
used if indicated. If the target lesion was not suitable for 
endovascular revascularization, surgical revascularization 
was performed. Surgical procedures included bypass or 
endarterectomy. Before surgical intervention, all patients 
were seen by a cardiologist to evaluate operative risk and to 
optimize cardiac status. Conservative treatment was followed 
in patients with significant comorbidities (unfit for surgery) 
who responded favorably on pain reduction therapy and in 
patients who did not consent to other therapies.
Definitions
Major amputation was defined as all amputations above 
the ankle.1 Time of major amputation during the study 
period was categorized into three classes: 1) primary 
amputation; 2) secondary amputation within 3 months 
after primary intervention and 3) secondary amputation 
after 3 months following primary intervention. Primary 
amputation is defined as amputation without an earlier 
attempt at revascularization and may be indicated in the 
absence of outflow vessels, in case of extensive gangrene 
or infection, or in the presence of severe comorbidities. 
This in contrast to secondary amputation is indicated when 
vascular interventions have failed or when the limb con-
tinues to deteriorate despite the presence of a successful 
revascularization.1 Secondary amputation within 3 months 
was considered to be the result of a failed attempt of pri-
mary treatment (conservative management, endovascular 
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revascularization or surgical revascularization). Secondary 
amputation after 3 months of initial therapy was considered 
to be progression of the disease. Indications for amputation 
were non-reconstructable arterial occlusive disease, exten-
sive gangrene or severe infection present at initial vascular 
evaluation and patients who were unfit for reconstruction 
due to flexion contracture, significant comorbidities or 
terminal illness.
Conservative treatment was considered to be adequate 
analgesia, antibiotics and wound debridement or minor 
amputation (below the ankle).
Outcome end points
After discharge follow-up was continued in the outpatient 
clinic, patients were evaluated for reinterventions and sur-
vival until December 2014. Primary outcome was mortality 
after major amputation. Mortality data were obtained using 
a community-based registry, the COMPET&T database from 
the company T&T Eindhoven. Secondary outcome measures 
were effect of timing of amputation on mortality and patient-
related factors associated with mortality.
statistical analysis
Categorical baseline characteristics of the patient group were 
reported as (relative) frequencies. Numeric variables were 
reported as mean and standard deviation values or, when 
appropriate, as median and range values. As the survival 
analyses were related to (time of) major amputation and 
should only be concerned with unique patients, the following 
rules for selecting the leg of interest were applied for patients 
with both legs affected. The amputated leg was included. 
If both or no legs were amputated, the earlier treated leg was 
chosen. Possible occurrence and time of major amputation of 
the contralateral leg were also taken as explanatory variables 
in the analyses.
In survival analyses after major amputation, the explana-
tory variable of interest was time of amputation: primary inter-
vention and secondary amputation ,3 months and .3 months 
of initial therapy (revascularization or conservative manage-
ment). In this subgroup, follow-up started at the moment of 
major amputation, which was defined as time zero. Survival 
probabilities were estimated using the product-limit (Kaplan–
Meier) method. Effect of time of amputation was tested using 
the log-rank test. In order to take account of the possibly 
confounding effect of covariables, we used the Cox propor-
tional hazards regression model. The following covariables 
were entered along with the categorical variable time of 
amputation: age in years as time-dependent covariable, 
amputation of the contralateral leg (Y/N) as time-dependent 
indicator variable, diabetes (Y/N), hypertension (Y/N), renal 
failure (Y/N), heart failure (Y/N) and Rutherford score 
(5 and 6 vs 4).
Effects of the explanatory variables in the Cox propor-
tional hazards model on survival were expressed by means of 
mortality rate ratios (RRs). Estimated effects were considered 
statistically significant if their P-values dropped to ,0.05. 
Statistical analyses were performed using SPSS 22.0.
Results
Patient selection and patient 
characteristics
During the study period, 651 patients (685 legs) were 
treated for CLI. In 168 (26%) patients, a major amputa-
tion was performed (Figure 1). In 10 patients, a major 
amputation of the contralateral leg was also performed. 
Baseline characteristics are shown in Table 1. The median 
age at the time of major amputation was 80 years (range 
70–95 years). In the major amputation group, 58% of 
patients were male (P=0.019). Presence of diabetes was 
61% in the amputation group versus 45% in the non-
amputation group (P,0.001). Renal failure was present 
in 27% versus 17% patients in the amputation group and 
non-amputation group, respectively (P=0.003). A higher 
Rutherford classification was found in the amputation 
group (P,0.001), and the number of outflow arteries was 
less in patients who underwent an amputation (P,0.001) 
compared to the non-amputation group.
Out of the 178 major amputations, a primary amputation 
was performed in 47 (26%) cases. Indications for primary 
amputation are listed in Table 2. A secondary amputa-
tion was performed in 131 cases, with 70 cases within 
3 months and 61 cases after 3 months following primary 
treatment (Figure 1). Initial treatments before secondary 
major amputations were conservative (n=21), endovascular 
revascularization (n=72) and surgical (n=38). In seven (4%) 
patients, a higher level of amputation was performed after 
a major amputation. The TASC classification was similar 
among the various treatment groups (aortoiliac: P=0.22, 
femoro popliteal: P=0.40).
Mortality after major amputation
Total follow-up in the subgroup of 168 major amputation 
patients amounted to 3,550 person-months during which 
132 deaths occurred, yielding an overall mortality rate of 
0.45/patient/year. All-cause overall mortality after major 
amputation was 44%, 66% and 85% after 1, 3 and 5 years, 
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respectively (Kaplan–Meier estimates; Table 3). All-cause 
mortality in patients treated for CLI without amputation was 
27%, 49% and 61% after 1, 3 and 5 years. Mortality after 
primary treatment in patients who underwent an amputation 
(primary or secondary during follow-up) and in patients 
treated without amputation (conservative, endovascular or 
surgical) is presented in Figure 2 (P,0.001).
There was no significant difference in mortality in pri-
mary versus secondary amputation (Kaplan–Meier estimates, 
P=0.6; Figure 3). The difference in mortality rates between 
the amputation time categories is presented in Table 4 
(log-rank test; P=0.67). In all, 1-year mortality after major 
amputation was 41% in patients aged 70–79 years and 48% 
in patients aged $80 years (P=0.073, log-rank test; Table 4). 
Time of amputation (primary or secondary amputation) 
adjusted for age also did not reach significance (P=0.59, 
stratified log-rank-test).
Estimated mortality RRs resulting from Cox proportional 
hazards regression are presented in Table 5. The effect of 
all variables simultaneously on mortality was significant 
(P=0.002). The effect of time of major amputation on sur-
vival was not significant (overall P=0.59), adjusted for the 
other variables presented in the table. Relative to patients 
undergoing primary amputation (45 patients), the mortality 
RRs of amputations performed within 3 months (67 patients) 
or later (56 patients) after primary intervention were 1.26 
(P=0.32) and 1.20 (P=0.46), respectively. The RR of the 
effect on mortality of a major amputation of the contralat-
eral leg taking place (12 patients) was 1.28 (P=0.60). This 
variable is time dependent as its effect only holds after 
amputation of the contralateral leg had taken place. The 
effect of aging showed an RR of 1.04: per year of age, the 
mortality rate increased by 4% (P=0.005). Other variables in 
the model such as Rutherford classification and comorbidity 
(diabetes mellitus, renal failure, hypertension, heart failure) 
had no significant effect on mortality after major amputa-
tion (Table 5).
Discussion
The survival after major amputation in elderly patients 
aged 70 years or older with CLI was poor, with mortality 
rates of 44% after 1 year and 85% after 5 years. The mor-
tality rates were higher in patients who underwent a major 
amputation compared to patients treated by revasculariza-
tion or by conservative treatment. The survival after major 
amputation in patients with CLI is poor; however, only a 
few studies reported on mortality rates after amputation in 
elderly patients. Pell and Stonebridge9 described an overall 
1-year mortality rate of 37% following major amputation 
in elderly. The lower mortality might be due to the younger 
population compared to our study. In addition, a considerable 
number of patients who underwent a major amputation were 
non-ambulatory pre operation. Non-ambulatory status is a 
negative predictor of outcome after major amputation.8
Figure 1 Patient selection.
Notes: numbers presented are the number of treated legs. *Primary amputation: no attempt of revascularization. **secondary amputation: amputation after revascularization/
conservative management/minor amputation. ***Conservative management includes analgesia, antibiotics, wound care and minor amputation.
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Analysis of time of amputation revealed no significant dif-
ference in death between primary and secondary amputation 
within 3 months after revascularization. This suggests that 
an attempt of revascularization can be performed. This cor-
responds to the results of Faglia et al10 who reported that the 
mortality in patients who had primary amputation in diabetics 
with CLI was worse than those who underwent revascular-
ization and then an amputation. Interestingly, in our study, 
a trend of a higher mortality is seen, especially in patients 
older than 80 years. The 1-year mortality was 63% in this 
subgroup. This is much higher than the 30% in primary ampu-
tations and 44% in late (.3 months) amputations. The 30-day 
mortality was even three to almost six times higher. Some had 
nonsuccessful interventions, and some lost their legs either 
due to occluded revascularization or despite patent bypasses 
or treated arteries. Particularly, these patients might benefit 
from primary amputation. Conservative treatment likely 
helped to decrease perioperative mortality after primary 
amputations, by simply not operating. These results suggest 
that failed attempt of revascularization should be avoided in 
octogenarians. In selected patients, primary amputation may 
be a reasonable therapeutic strategy, as it could potentially 
prevent repetitive interventions and hospital admissions. 
Owing to the design of the study, it was not possible to make 
Table 1 Patient characteristics
Variable Amputation, 
n=168 (%)
No amputation, 
n=483 (%)
P-value
Age, years
70–79 86 (51) 255 (53) 0.69
.80 82 (50) 228 (48)
gender
M 98 (58) 229 (48) 0.019
F 70 (42) 254 (52)
Rutherford classification
rutherford 4 34 (20) 169 (35) ,0.001
rutherford 5–6 134 (80) 314 (65)
risk factors and comorbidity
smoking 42 (26) 156 (32) 0.056
hypertension 117 (70) 311 (65) 0.24
Diabetes 103 (61) 216 (45) ,0.001
renal failure 46 (27) 82 (17) 0.003
heart failure 65 (39) 119 (25) 0.001
COPD 51 (30) 124 (26) 0.36
Ambulatory status
Ambulatory 103 (61) 387 (80) ,0.001
non-ambulatory 36 (22) 26 (5)
Missing 29 (17) 70 (15)
TASC classification – aortoiliac
no lesion 102 (61) 281 (58) 0.26
Type A 17 (10) 75 (16)
Type B 10 (6) 30 (6)
Type C 4 (2) 17 (4)
Type D 5 (3) 31 (6)
TASC classification – femoropopliteal
no lesion 16 (10) 40 (8) 0.25
Type A 16 (10) 50 (10)
Type B 60 (36) 173 (36)
Type C 31 (19) 129 (27)
Type D 25 (15) 52 (11)
Outflow tibial arteries
none 11 (7) 17 (4) ,0.001
1 vessel 73 (44) 135 (28)
2 vessels 42 (25) 153 (32)
3 vessels 14 (8) 114 (24)
Missing 28 (17) 64 (13)
Abbreviations: M, male; F, female; COPD, chronic obstructive pulmonary disease; 
TAsC, Trans Atlantic Intersociety Consensus.
Table 2 Indications for primary major amputation (n=47)
Indication n (%)
non-reconstructable 18 (38)
Progression wound/extensive gangrene 14 (30)
sepsis 4 (9)
Unfit for intervention 11 (23)
Table 3 Mortality after major amputation
Time Overall mortality in the major 
amputation subgroup of 168 patients
% (SE) Deaths (n) Remaining 
at risk (n)
Major 
amputation
30 days 14.3 (2.7) 24 144
6 months 38.2 (3.8) 64 103
1 year 44.3 (3.8) 74 90
3 years 65.6 (3.8) 106 39
5 years 85.1 (3.4) 126 13
Abbreviation: se, standard error.
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Figure 2 Kaplan–Meier curve.
Note: Mortality after primary treatment in patients who underwent a major amputation 
(primary and secondary; n=168) versus patients treated without amputation (n=505).
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Revascularization of the lower extremity remains the 
treatment of choice for most patients with CLI. Therapeutic 
options have significantly increased after introduction and 
improvement of less invasive techniques such as endovas-
cular therapy.11 Owing to these advances, there appears to be 
a decline in overall major amputation rates associated with 
a corresponding increase in revascularizations. Although 
technical advances may have resulted in a steadiness or even 
decrease in amputations, comparisons of total amputations 
over a longer period suggest an increase.12 Presumably, this 
effect is attributable to an aging population, because of late 
referral to vascular surgeons, but perhaps more importantly, 
because there is no agreed upon definition of non-salvage-
able limb.13,14 An amputation rate of 26% as shown in our 
population is comparable to the amputation rate described by 
TASC II.1 Recently, a study containing a large cohort reported 
on the 1-year amputation rate in CLI within a wide range 
from 5% to 57% depending on Rutherford classification.3 
These data are in accordance to our results. The amputation 
rate can be explained by the higher incidence of diabetes and 
renal failure and also the high non-ambulatory status in our 
study population. Additionally, the majority of the patients 
had a high Rutherford classifica tion. Amputation frequencies 
up to 77% are reported in studies including patients with 
diabetics and CLI.10,15 Higher rates in these studies could be 
explained by a different pathophysiology of atherosclerosis 
in diabetic patients. In our population, the most common 
indication for primary amputation was extensive gangrene 
or non-reconstructable arteries (67%). Unreconstructable 
vascular disease was the most common indication for second-
ary amputation, accounting for ~53% of the patients, which 
corresponds to the 60% mentioned in TASC II.1

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   

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Figure 3 Kaplan–Meier curve.
Note: Mortality after primary amputation and secondary amputation (n=168).
Table 4 Cumulative mortality probabilities of primary amputation 
and secondary amputation in patients aged 70–79 years 
versus $80 years
Timing amputation Time Mortality
70–79 years $80 years
n=84 n=84
Overall (P=0.073)* 30 days 13% 15%
6 months 34% 43%
1 year 41% 48%
3 years 57% 76%
5 years 80% 91%
n=25 n=20
Primary amputations 
(P=0.67)*
30 days
6 months
12%
24%
5%
30%
1 year 44% 30%
3 years 57% 66%
5 years 84% 91%
n=35 n=32
Amputation ,3 months 
after intervention (P=0.17)*
30 days
6 months
17%
37%
28%
59%
1 year 43% 63%
3 years 54% 80%
5 years 80% 87%
n=24 n=32
Amputation .3 months 
after intervention (P=0.35)*
30 days
6 months
8%
39%
9%
34%
1 year 39% 44%
3 years 62% 77%
5 years 72% 88%
Note: *P-values are based on the log-rank test of the null hypothesis that survival is 
the same in both age groups.
Table 5 estimated mortality rrs using Cox proportional hazards 
model in 168 patients of whom 132 died after major amputation
Variable RR (95% CI) P-value
Time of amputation 0.59
Primary amputation 1
Amputation within 3 months 1.26 (0.81–1.95) 0.32
Amputation after 3 months 1.20 (0.74–1.94) 0.46
Amputation of contralateral leg 
(time dependent)
1.28 (0.50–3.27) 0.60
Age in years (time dependent) 1.04 (1.01–1.07) 0.005
Diabetes mellitus 1.36 (0.94–1.97) 0.10
renal failure 1.47 (0.99–2.20) 0.057
hypertension 0.81 (0.54–1.21) 0.30
heart failure 1.42 (0.98–2.05) 0.063
Rutherford classification 1.57 (0.98–2.51) 0.061
Note: Significance of the model: P=0.002 (χ2=26.529 with nine df).
Abbreviations: rr, rate ratio; df, degrees of freedom.
a prediction model for failure of revascularization. Further 
research should indicate if timing of amputation has an influ-
ence on mortality. In addition, patient-related outcomes as 
quality of life should be assessed.
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Mortality after major amputation in elderly with ClI
Treatment of CLI should be tailored to the individual 
patient. Therefore, initiating the most suitable therapy can be a 
challenge for vascular surgeons. Predictive risk factors might 
facilitate in the difficult decision-making. Outcome does not 
appear to be adversely influenced by system-related factors 
but is determined by patient-specific factors. Amputation is 
mostly performed in patients with serious comorbidity, severe 
wounds or gangrene and no revascularization options, which 
makes it a poor patient population in advance. Comorbidity, 
end-stage renal disease, major tissue loss, dependent living 
situation, non-ambulatory status and non-White ethnicity are 
reported to be significant patient-related risk factors for death 
after major primary amputation.16 Age was also reported to 
have an adverse effect on survival.9 Between the two age 
groups, 70–79 years and 80 years or older, no significant 
difference in mortality was observed (P=0.073). When ana-
lyzing age as a continuous time variable however, our results 
showed age as a significant risk factor for mortality (P=0.005). 
Besides age, there was a trend in renal failure (P=0.057), heart 
failure (P=0.063) and Rutherford classification (P=0.061) as 
risk factors for death after major amputation. Aulivola et al17 
found end-stage renal disease as a risk factor for death at 1 and 
5 years (51.9% and 14.4% vs 75.4% and 42.2%; P,0.001). 
In contrast to our results, a recent meta-analysis showed that 
diabetes has an association with an increased risk of all-cause 
mortality in patients with CLI.18 The analysis reported a sig-
nificant lower survival rate in patients with diabetes after a 
major amputation, whereas we found a higher mortality RR, 
nonetheless a nonsignificant effect on survival. The number 
of patients included in this study might be too small to show 
significance. In addition, no significant adverse effect of 
hypertension on mortality was found, with an RR of 0.81. 
This might be the result of treatment of hypertension.
Conclusion
Despite developments in the treatment of CLI by revascu-
larization, amputation rates remain high. Major amputations 
continue to be associated with tremendous mortality rates 
compared to conservative treatment, endovascular revascu-
larization and surgical revascularization.
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